Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
ALPCO Receives FDA 510(k) Clearance for the Calprotectin Immunoturbidimetric Assay
American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, today announced recent FDA 510(k) clearance of its Calprotectin Immunoturbidimetric Assay. The Calprotectin Immunoturbidimetric (IT) Assay is now IVDD and 510(k)-cleared for in... - June 15, 2023 - ALPCO
ClinicalPURSUIT is Currently Offering a Free Demonstration of Their State-of-the-Art Clinical EDC System
The Missouri-based EDC systems provider is helping clinicians, data managers, and CROs with seamless data capturing through their world-class software and solutions and free demos. - June 13, 2023 - ClinicalPURSUIT
Hemanext Announces a Strategic Partnership and Investment from Vitalant
Partnership to include research and development at Vitalant Innovation Center. - June 07, 2023 - Hemanext
Opening New Frontiers in Oral Care and the Cannabinoid Market
A groundbreaking patent has been unveiled, presenting a revolutionary method for the prevention and treatment of dental pulp-associated diseases using a cannabinoid-based composition. This patent offers pharmaceutical companies a unique opportunity to enter the rapidly growing cannabinoid market while addressing critical dental care needs. - June 04, 2023 - CannIBite
Sonar Clinical Research Diversity in Clinical Trials Summit Signifies a Significant Achievement in Promoting Healthcare Equity Within the Community
The Diversity in Clinical Trials Summit, held on April 22nd 2023, at The Gathering Spot, Atlanta Ga proved to be an extraordinary community event focused on promoting diversity and inclusion within the field of clinical research. The summit brought together renowned experts, thought leaders,... - June 04, 2023 - Sonar Clinical Research
New Research Benchmarks Biopharmaceutical Perceptions of Global CRO Thought Leadership
Landmark Research Analyzes Perspectives of US and EU Biopharma C-Suite, Clinical Operations and Medical/Regulatory Affairs Professionals on Global CRO Thought Leadership. - June 01, 2023 - Life Science Strategy Group, LLC
Huntington Study Group Announces Call for Abstracts for 30th Annual Meeting
The Huntington Study Group (HSG), with a mission of accelerating treatments that make a difference for those impacted by Huntington’s disease, together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease... - June 01, 2023 - Huntington Study Group
TwitchView® Train of Four Monitor Used to Eliminate Residual Neuromuscular Blockade
ASA guideline first author Dr. Stephan Thilen et al. reports exciting results from a protocol that completely eliminated post-operative residual neuromuscular blockade (PRNMB). Of note, Thilen et al. achieved this groundbreaking advance in patient safety using the TwitchView® Train of Four (TOF) monitor while maintaining a role for neostigmine as a reversal strategy, resulting in pharmacologic cost savings of $42 per patient. - May 30, 2023 - Blink Device Company
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease in The Lancet Neurology. - Statistically Significant Improvement in Chorea Associated with Huntington’s Disease... - May 19, 2023 - Huntington Study Group
GARM Clinic Introduces GARM Community: a Patient-Centric Initiative to Foster Healthier Living and Stronger Connections
The GARM Clinic, a pioneer in regenerative medicine, proudly announces the launch of the GARM Community, a groundbreaking initiative designed to enhance patient care, create a sense of belonging, and promote healthier living for past, present, and future patients. This innovative program aims to... - May 19, 2023 - GARM Clinic
Huntington Study Group Achieves Last Patient Last Visit for Its Observational Study to Test Virtual Use of the Unified Huntington’s Disease Rating Scale®
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., announces an important milestone in the novel observational study Virtual Unified Huntington’s Disease Rating Scale (vUHDRS™). The last participant completed the last visit, marking... - May 16, 2023 - Huntington Study Group
MPFI Researcher Receives Prominent Award to Launch New Lab
The Max Planck Florida Institute for Neuroscience announces that Dr. Madineh Sarvestani has been named a Freeman Hrabowski Scholar by the Howard Hughes Medical Institute. The award provides up to $8.6 million for five to 10 years to support outstanding early-career faculty members who have strong potential to become leaders in the field and who are committed to advancing diversity, equity, and inclusion in science through their mentorship of trainees from populations underrepresented in science. - May 09, 2023 - Max Planck Florida Institute for Neuroscience
Northern College and the Canadian College of Naturopathic Medicine Announce Collaboration
Memorandum of Understanding underscores current need to increase access for health care learners and develop health care resources in northern communities - May 03, 2023 - Canadian College of Naturopathic Medicine
NanoCellect Biomedical Announces New Distribution Partnerships in Asia and Europe
NanoCellect Biomedical, the leading provider of microfluidic flow cytometry platforms, has announced new distributor partnerships in Asia and Europe to expand its global reach and provide greater accessibility to its innovative technologies. - April 26, 2023 - NanoCellect Biomedical
Thermo Fisher Partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust... - April 17, 2023 - ALPCO
Black Students in Pittsburgh 3-D Print Living Artery as Part of C-3PO Project
In the C-3PO project of The Citizen Science Lab, African American high school and middle school students have 3-D printed their first living body part. - April 12, 2023 - The Citizen Science Lab
Trent University and Canadian College of Naturopathic Medicine Partner to Create New Pathways to Careers in Holistic Healthcare
Memorandum of Understanding Establishes Partnership for Innovative Research and Program Collaboration - April 11, 2023 - Canadian College of Naturopathic Medicine
HSG and HD-CAB Collaborate to Provide Global Patient Advisory Board
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), recently collaborated with Huntington’s Disease – Community Advisory Board (HD-CAB) to provide a... - March 30, 2023 - Huntington Study Group
New Research on Decentralized Clinical Trial (DCT) Strategies to Boost Patient Diversity
Current and Future Clinical Trial Participants Link Enhanced Diversity and Inclusion of Underrepresented Patient Populations to DCT - March 29, 2023 - Life Science Strategy Group, LLC
World Class Hospitals Join DNA Damage Response Consortium to Bring Forward New Treatments for Adults and Children with Brain Cancer
Researchers from St. Jude Children’s Research Hospital, NYU, UCSF, and the University of Minnesota join National Brain Tumor Society and Yale-led Initiative - March 29, 2023 - National Brain Tumor Society
Emmanuel J. Ajala Honored as a Professional of the Year for 2023 by Strathmore’s Who’s Who Worldwide
Emmanuel J. Ajala, of Bronx, New York, has been recognized as a Professional of the Year for 2023 by Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of research. About Emmanuel J. Ajala Emmanuel J. Ajala is a biomedical... - March 29, 2023 - Strathmore Worldwide
HSG Announces 30th Annual Meeting
The Huntington Study Group (HSG), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently announced that their 2023 Annual Meeting will be held November 2-4, 2023 at the Sheraton Grand at Wild Horse Pass in Chandler, AZ, a... - March 21, 2023 - Huntington Study Group
Diversity in Clinical Trials Summit 2023
Upcoming Diversity in Clinical Trials Summit Aims to Address Disparities and Improve Patient Outcomes. - March 20, 2023 - Sonar Clinical Research
Breaking Barriers: ALS TDI Unveils Groundbreaking ALS Research Collaborative (ARC) to Accelerate Global Research in ALS
The ALS Research Collaborative will revolutionize ALS research by providing scientists with unprecedented access to the data and tools they need to discover new treatments and accelerate progress toward cures for ALS. - March 15, 2023 - ALS Therapy Development Institute
Disability Advocates Announce Endorsement of the All of Us Research Program
The American Association on Health and Disability announces the release of “No Research About Us Without Us," a statement endorsing the National Institutes of Health’s All of Us Research Program, an effort to engage more than one million people from across the United States in biomedical research to advance health care for all. - March 15, 2023 - American Association on Health and Disability
New Research Identifies Latest Clinical Development and CRO Outsourcing Trends in China
Groundbreaking Research Explores the Chinese Innovative Biopharmaceutical Clinical Development Market, CRO Outsourcing and Future Growth with Over 100 Chinese Biopharma Professionals - March 15, 2023 - Life Science Strategy Group, LLC
Creative Biolabs Looks Forward to a Year of Prosperity for Exosome Studies
Creative Biolabs expressed hopes that further progress could be made in the field of exosome research. - March 08, 2023 - Creative Biolabs
NeuroSolution Center of Austin Introduces Innovative Laser Activated PRP Procedure for Restorative Medicine
The NeuroSolution Center of Austin has announced a revolutionary treatment, the Laser Activated Platelet Rich Plasma (PRP) procedure. Developed with the expertise of renowned neurosurgeon Dr. Marcella Madera, the procedure harnesses the regenerative power of PRP, enhanced by laser activation. Suitable for a range of conditions, it offers a natural alternative to traditional medical interventions, and future rounds of the procedure are scheduled for interested individuals. - February 26, 2023 - Neurosolution
Memorial Healthcare Institute for Neuroscience Raises the Bar for Patient-Centered Care with AwareNow Health Streams
In partnership with Awareness Ties, Memorial Healthcare Institute for Neuroscience is pioneering a new level in patient-centered care. With AwareNow Health Streams, the Institute for Neuroscience at Memorial Healthcare is closing the gap between the patient and the provider while setting a new standard in care. - February 20, 2023 - Awareness Ties
Santa Fe BioLabs Develops Optimized and Selective Media for the Pathogenic Yeast Candida auris and is Awarded Wide-Ranging Patent for Design of Selective Microbial Media
Santa Fe BioLabs concluded development of ReCand, a medium for optimized colony formation of dry Candida auris, and AuriFind, a medium for identification by selective growth of viable Candida auris. A patent has been granted for media development based on the underlying principle of modulation of toxicity by quaternary ammonium compounds. - February 16, 2023 - Santa Fe BioLabs LLC
Arbor Hemp and Global Healthcare Ambassador Mieko Perez Launch "Arbor by Mieko Perez" Clinically Studied Product Line
Globally recognized healthcare ambassador brings more than a decade of experience in support of consumer buyer trends and product knowledge to Arbor Hemp for her own clinical studied product line. - February 10, 2023 - Arbor Hemp
Huahai Vitiligo Hospital Accomplishes Twelve Medical Publications
Huahai Vitiligo Hospital successfully published twelve medical publications in 2014. - February 10, 2023 - Huahai Vitiligo Hospital
The Matter of a Child's Heart
Parents and Founders of new nonprofit have a special reason to focus on heart health this February during American Heart Health Month. - February 07, 2023 - Strongest Hearts
The Retreat Announces the Curtis Carlson Nelson Research Institute to Focus on Addiction and Recovery Research, Advocacy
The Retreat is announcing The Curtis Carlson Nelson Research Institute at The Retreat. Created to honor the legacy of longtime friend Curtis Carlson Nelson, it will focus on research and advocacy into substance abuse and recovery. The first project will study outcomes for Twelve Step, abstinence- and community-based recovery models. The research will be conducted by Dr. John Kelly of Harvard Medical School, Massachusetts General Hospital and the Recovery Research Institute. - February 02, 2023 - The Retreat
New York Cancer & Blood Specialists Expands Cancer Care Network to Upstate Locations
New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the nation, and OneOncology, the national platform for independent community oncology practices, announce its plan to expand cancer care access to Orange County. The expanded footprint will provide patients... - January 30, 2023 - New York Cancer & Blood Specialists
The Canadian College of Naturopathic Medicine and Southern Cross University of Australia Announce Collaboration
International collaboration highlights reach and depth of naturopathic education around the world. The Canadian College of Naturopathic Medicine (CCNM) and the National Centre for Naturopathic Medicine at Southern Cross University (SCU), Australia have signed a memorandum of understanding (MOU)... - January 19, 2023 - Canadian College of Naturopathic Medicine
DFW Orthopedic Surgeon and Shoulder Specialist, Howard W. Harris, MD, Introduces New and Innovative Shoulder Replacement Technology from FX Shoulder Solutions
Dallas/Fort Worth's Howard W. Harris, MD, the shoulder expert and one of the many gifted surgeons at Texas Orthopedic Specialists PLLC, has collaborated with FX Shoulder Solutions on new shoulder reconstruction technology. - January 12, 2023 - Howard W. Harris, MD
Huntington Study Group Names First Chief Innovation Officer
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, today announced Brett Kinsler has been named to the newly created position of Chief Innovation Officer (CINO). - January 10, 2023 - Huntington Study Group
ClinicalPURSUIT’s Patient Registry Solution is Transforming the Way Researchers Collect Critical Medical Data
The leading EDC technology provider is helping researchers by providing them with quality patient registry solutions that assist in efficient medical data collection. - December 28, 2022 - ClinicalPURSUIT
Paras Biopharmaceuticals Creates Excellence with “Continuous Biomanufacturing”: Achieves Objectives of “High Productivity & Biomanufacturing Innovation”
With 6 years of dedicated work at Paras Biopharmaceuticals and the use of Paras Biopharmaceuticals’ unique technology platform (which comprises of Bioproduction technologies for economical production of biologics), the company is pleased to announce that an excellent scale-up production process is achieved with “Continuous Biomanufacturing.” - December 19, 2022 - Paras Biopharmaceuticals Finland Oy
Clinical Research Organization, Huntington Study Group “Firsts” Continue
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) through its Clinical Research Organization (CRO), HSG Clinical Research, Inc. (HSGCR) continues making groundbreaking progress in the HD world. At their Annual Meeting in November, the... - December 05, 2022 - Huntington Study Group
UserWise, LLC Launches Its First eLearning Catalog
UserWise, LLC, a San Jose, California-based Human Factors consultancy, has launched UserWise University, another step towards helping develop safe and usable medical devices. - December 01, 2022 - UserWise, LLC
Vesalio Appoints VP of U.S. Sales and Announces Recent Publication on NeVa Showing Impressive First Pass Rates
Vesalio hires Bob Bushok as VP of U.S. Sales and announces high first-pass rates and favorable safety profile in a 145-stroke patient data set for the NeVa™ thrombectomy device with findings published in the journal Interventional Neuroradiology. - November 29, 2022 - Vesalio
Huntington Study Group Annual Meeting
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD), recently held its 29th Annual Meeting in Tampa, FL. This renowned meeting brings together HD thought leaders, scientific experts, industry partners and sponsors, advocacy groups, and... - November 29, 2022 - Huntington Study Group
Personalized Immune Therapy Shown to Extend Survival in Patients with Aggressive Brain Cancer
DCVax®-L Cancer Vaccine Trial at Sarah Cannon Research Institute at HealthONE Shows First Meaningful Survival Extension in Many Years - November 22, 2022 - HCA Healthcare Continental Division
Biomed Industries, Inc. Comments on Roche’s Alzheimer’s Phase III Trial
In a news release dated November 14, 2022, Roche announced that their Alzheimer’s drug candidate, gantenerumab, did not perform meaningfully better than a placebo. About 25% of all patients who received gantenerumab were also associated with higher rates of an imaging abnormality that can... - November 19, 2022 - Biomed Industries Inc.
Pregmune Joins Digital Twin Consortium
Pregmune is thrilled to announce that has recently joined the Digital Twin Consortium (DTC), a global initiative created with the goal to be The Authority in Digital Twin(TM) as it relates to policy, security, interoperability, and overall development of digital twins. Founded in 2020 by Dr. - November 17, 2022 - Pregmune
DataJoint Launches New Cloud-Based System for Automating Neuroscience Experiments
DataJoint's New Cloud Solution Improves Lab Efficiency and Accuracy - November 11, 2022 - DataJoint
New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings
GeneFluidics, Inc. is pleased to announce a joint publication with the Medical College of Wisconsin (MCW) that introduces rapid antimicrobial susceptibility testing (AST), which would represent a paradigm shift in the clinical management of microbial infections. The data from the MCW study have... - November 04, 2022 - GeneFluidics Inc.
Long COVID Care Center Have Recently Published a Medical Report on the Symptoms of Long COVID Brain Fog
During rehabilitation after being infected with COVID-19, many patients said they experienced "brain fog." According to figures given in the study report, about 10% of patients infected with COVID-19 will experience long COVID. At present, it has become customary in the medical community to classify the symptoms of brain and nerve caused by COVID-19 infection as long-term COVID brain fog. - October 26, 2022 - Long COVID Care Center